CIK 0001433607 · Non-accelerated filer<br>Smaller reporting company
InspireMD, Inc.
Sign in to watch- Ticker
- NSPR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262123838
- Phone
- (888) 776-6804
- Business address
- 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
- Former names
- Saguaro Resources, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-27 | Gleason Shane Thomas Chief Commercial Officer | Sale | −3,858 | $2.71 | $10K | 1,135,319 |
| 2025-01-07 | Ward Scott R. Director | Grant or award | +16,245 | 59,793 | ||
| 2025-01-07 | Ward Scott R. Director | Grant or award · Options to purchase common stock (right to buy) | +7,418 | 24,065 | ||
| 2025-01-07 | Verta Patrick EVP Clinical/Medical Affairs | Grant or award | +83,072 | 311,532 | ||
| 2025-01-07 | Verta Patrick EVP Clinical/Medical Affairs | Grant or award · Options to purchase common stock (right to buy) | +37,933 | 117,281 | ||
| 2025-01-07 | Tommasoli Andrea Chief Operating Officer | Grant or award | +232,616 | 727,694 | ||
| 2025-01-07 | Tommasoli Andrea Chief Operating Officer | Grant or award · Options to purchase common stock (right to buy) | +106,218 | 282,917 | ||
| 2025-01-07 | Stuka Paul Director | Grant or award | +48,736 | 360,284 | ||
| 2025-01-07 | Stuka Paul Director | Grant or award · Options to purchase common stock (right to buy) | +22,254 | 128,129 | ||
| 2025-01-07 | Slosman Marvin CEO and President | Grant or award | +558,417 | 2,410,536 | ||
| 2025-01-07 | Slosman Marvin CEO and President | Grant or award · Options to purchase common stock (right to buy) | +254,985 | 937,796 | ||
| 2025-01-07 | Shore Craig CFO and CAO | Grant or award | +232,616 | 1,112,460 | ||
| 2025-01-07 | Shore Craig CFO and CAO | Grant or award · Options to purchase common stock (right to buy) | +106,218 | 417,706 | ||
| 2025-01-07 | ROUBIN GARY S Director | Grant or award | +32,491 | 534,279 | ||
| 2025-01-07 | ROUBIN GARY S Director | Grant or award · Options to purchase common stock (right to buy) | +14,836 | 91,743 | ||
| 2025-01-07 | Kester Thomas J Director | Grant or award | +32,491 | 359,143 | ||
| 2025-01-07 | Kester Thomas J Director | Grant or award · Options to purchase common stock (right to buy) | +14,836 | 84,947 | ||
| 2025-01-07 | Gleason Shane Thomas Chief Commercial Officer | Grant or award | +232,616 | 746,981 | ||
| 2025-01-07 | Gleason Shane Thomas Chief Commercial Officer | Grant or award · Options to purchase common stock (right to buy) | +106,218 | 289,346 | ||
| 2025-01-07 | BERMAN MICHAEL Director | Grant or award | +32,491 | 264,533 |
Page 5 of 10 · 195 trades